Back
Corcept Therapeutics Stock Price Chart
Sponsored
CORT
Sponsored
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Buy
78
CORT
Corcept Therapeutics
Last Price:
$59.03
Seasonality Move:
9.2%
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Corcept Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.61 | Buy |
20-day SMA: | 52.28 | Buy |
50-day SMA: | 55.14 | Buy |
200-day SMA: | 39.44 | Buy |
8-day EMA: | 54.83 | Buy |
20-day EMA: | 53.66 | Buy |
50-day EMA: | 52.84 | Buy |
200-day EMA: | 42.64 | Buy |
Corcept Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 70.63 | Buy |
Chaikin Money Flow: | 1046947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.28 - 55.34) | Buy |
Bollinger Bands (100): | (41.3 - 56.64) | Buy |
Corcept Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 61.11 while CORT 8-day simple moving average is 53.61, which is a Buy signal.
-
The stock price of CORT is 61.11 while Corcept Therapeutics 20-day SMA is 52.28, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 55.14 while CORT share price is 61.11, making it a Buy technically.
-
CORT stock price is 61.11 and Corcept Therapeutics 200-day simple moving average is 39.44, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $61.11. The Score for CORT is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
6.4B
Price in USD:
61.11
Share Volume:
1.1M
Corcept Therapeutics 52-Week Range
52-Week High:
62.22
52-Week Low:
20.84
Buy
78
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 61.11 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 61.11 while CORT 8-day exponential moving average is 54.83, which is a Buy signal.
-
The stock price of CORT is 61.11 while Corcept Therapeutics 20-day EMA is 53.66, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 52.84 while CORT share price is 61.11, making it a Buy technically.
-
CORT stock price is 61.11 and Corcept Therapeutics 200-day simple moving average is 42.64, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.54 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 70.63, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (50.28 - 55.34), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (41.3 - 56.64), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.